| Literature DB >> 25701412 |
Ling-Na Zheng1, Meng Wang, Lei-Chao Zhao, Bao-Yun Sun, Bing Wang, Han-Qing Chen, Yu-Liang Zhao, Zhi-Fang Chai, Wei-Yue Feng.
Abstract
Cisplatin is a commonly used chemotherapeutic drug in cancer treatment, whereas Gd@C82(OH)22 is a new nanomaterial anti-tumor agent. In this study, we determined intracellular Gd@C82(OH)22 and cisplatin after treatment of Hela and 16HBE cells by single cell inductively coupled plasma-mass spectrometry (SC-ICP-MS), which could provide quantitative information at a single-cell level. The cell digestion method validated the accuracy of the SC-ICP-MS. The concentrations of Gd@C82(OH)22 and cisplatin in cells at different exposure times and doses were studied. The SC-ICP-MS is a promising complement to available methods for single cell analysis and is anticipated to be applied further to biomedical research.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25701412 DOI: 10.1007/s00216-014-8422-3
Source DB: PubMed Journal: Anal Bioanal Chem ISSN: 1618-2642 Impact factor: 4.142